Abraham Martín1, Nuria Vázquez-Villoldo2,3,4, Vanessa Gómez-Vallejo5,6, Daniel Padro5,7, Federico N Soria2,3,4, Boguslaw Szczupak5, Sandra Plaza-García5,7, Ander Arrieta5, Torsten Reese5,7, Jordi Llop5,6, Maria Domercq2,3,4, Carlos Matute8,9,10. 1. Molecular Imaging Unit, CIC biomaGUNE, P° Miramon 182, San Sebastian, Spain. amartin@cicbiomagune.es. 2. Department of Neurosciences, University of the Basque Country, Barrio Sarriena s/n, 48940, Leioa, Spain. 3. Achucarro Basque Center for Neuroscience, UPV/EHU, 48170, Zamudio, Spain. 4. Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), 48940, Leioa, Spain. 5. Molecular Imaging Unit, CIC biomaGUNE, P° Miramon 182, San Sebastian, Spain. 6. Radiochemistry and Nuclear Imaging, CIC biomaGUNE, P° Miramon 182, San Sebastian, Spain. 7. Magnetic Resonance Imaging, CIC biomaGUNE, P° Miramon 182, San Sebastian, Spain. 8. Department of Neurosciences, University of the Basque Country, Barrio Sarriena s/n, 48940, Leioa, Spain. carlos.matute@ehu.es. 9. Achucarro Basque Center for Neuroscience, UPV/EHU, 48170, Zamudio, Spain. carlos.matute@ehu.es. 10. Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), 48940, Leioa, Spain. carlos.matute@ehu.es.
Abstract
PURPOSE: Glutamate excitotoxicity contributes to oligodendroglial and axonal damage in multiple sclerosis pathology. Extracellular glutamate concentration in the brain is controlled by cystine/glutamate antiporter (system xc-), a membrane antiporter that imports cystine and releases glutamate. Despite this, the system xc(-) activity and its connection to the inflammatory reaction in multiple sclerosis (MS) is largely unknown. METHODS: Longitudinal in vivo magnetic resonance (MRI) and positron emission tomography (PET) imaging studies with 2-[(18)F]Fluoro-2-deoxy-D-glucose ([(18)F]FDG), [(11)C]-(R)-(1-(2-chlorophenyl)-N-methyl-N-1(1-methylpropyl)-3-isoquinolinecarboxamide ([(11)C]PK11195) and (4S)-4-(3-(18)F-fluoropropyl)-L-glutamate ([(18)F]FSPG) were carried out during the course of experimental autoimmune encephalomyelitis (EAE) induction in rats. RESULTS: [(18)F]FSPG showed a significant increase of system xc(-) function in the lumbar section of the spinal cord at 14 days post immunization (dpi) that stands in agreement with the neurological symptoms and ventricle edema formation at this time point. Likewise, [(18)F]FDG did not show significant changes in glucose metabolism throughout central nervous system and [(11)C]PK11195 evidenced a significant increase of microglial/macrophage activation in spinal cord and cerebellum 2 weeks after EAE induction. Therefore, [(18)F]FSPG showed a major capacity to discriminate regions of the central nervous system affected by the MS in comparison to [(18)F]FDG and [(11)C]PK11195. Additionally, clodronate-treated rats showed a depletion in microglial population and [(18)F]FSPG PET signal in spinal cord confirming a link between neuroinflammatory reaction and cystine/glutamate antiporter activity in EAE rats. CONCLUSIONS: Altogether, these results suggest that in vivo PET imaging of system xc(-) could become a valuable tool for the diagnosis and treatment evaluation of MS.
PURPOSE:Glutamate excitotoxicity contributes to oligodendroglial and axonal damage in multiple sclerosis pathology. Extracellular glutamate concentration in the brain is controlled by cystine/glutamate antiporter (system xc-), a membrane antiporter that imports cystine and releases glutamate. Despite this, the system xc(-) activity and its connection to the inflammatory reaction in multiple sclerosis (MS) is largely unknown. METHODS: Longitudinal in vivo magnetic resonance (MRI) and positron emission tomography (PET) imaging studies with 2-[(18)F]Fluoro-2-deoxy-D-glucose ([(18)F]FDG), [(11)C]-(R)-(1-(2-chlorophenyl)-N-methyl-N-1(1-methylpropyl)-3-isoquinolinecarboxamide ([(11)C]PK11195) and (4S)-4-(3-(18)F-fluoropropyl)-L-glutamate ([(18)F]FSPG) were carried out during the course of experimental autoimmune encephalomyelitis (EAE) induction in rats. RESULTS: [(18)F]FSPG showed a significant increase of system xc(-) function in the lumbar section of the spinal cord at 14 days post immunization (dpi) that stands in agreement with the neurological symptoms and ventricle edema formation at this time point. Likewise, [(18)F]FDG did not show significant changes in glucose metabolism throughout central nervous system and [(11)C]PK11195 evidenced a significant increase of microglial/macrophage activation in spinal cord and cerebellum 2 weeks after EAE induction. Therefore, [(18)F]FSPG showed a major capacity to discriminate regions of the central nervous system affected by the MS in comparison to [(18)F]FDG and [(11)C]PK11195. Additionally, clodronate-treated rats showed a depletion in microglial population and [(18)F]FSPG PET signal in spinal cord confirming a link between neuroinflammatory reaction and cystine/glutamate antiporter activity in EAE rats. CONCLUSIONS: Altogether, these results suggest that in vivo PET imaging of system xc(-) could become a valuable tool for the diagnosis and treatment evaluation of MS.
Authors: Dorothea Buck; Annette Förschler; Constantin Lapa; Tibor Schuster; Patrick Vollmar; Thomas Korn; Stefan Nessler; Christine Stadelmann; Alexander Drzezga; Andreas K Buck; Hans-Jürgen Wester; Claus Zimmer; Bernd-Joachim Krause; Bernhard Hemmer Journal: J Nucl Med Date: 2012-06-27 Impact factor: 10.057
Authors: Laura Airas; Alex M Dickens; Petri Elo; Päivi Marjamäki; Jarkko Johansson; Olli Eskola; Paul A Jones; William Trigg; Olof Solin; Merja Haaparanta-Solin; Daniel C Anthony; Juha Rinne Journal: J Nucl Med Date: 2015-01-08 Impact factor: 10.057
Authors: María Domercq; María Victoria Sánchez-Gómez; Catherine Sherwin; Estibaliz Etxebarria; Robert Fern; Carlos Matute Journal: J Immunol Date: 2007-05-15 Impact factor: 5.422
Authors: W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky Journal: Ann Neurol Date: 2001-07 Impact factor: 10.422
Authors: Akihiro Takano; Fredrik Piehl; Jan Hillert; Andrea Varrone; Sangram Nag; Balázs Gulyás; Per Stenkrona; Victor L Villemagne; Christopher C Rowe; Richard Macdonell; Nabil Al Tawil; Thomas Kucinski; Torsten Zimmermann; Marcus Schultze-Mosgau; Andrea Thiele; Anja Hoffmann; Christer Halldin Journal: EJNMMI Res Date: 2013-04-24 Impact factor: 3.138
Authors: Mirwais Wardak; Ida Sonni; Audrey P Fan; Ryogo Minamimoto; Mehran Jamali; Negin Hatami; Greg Zaharchuk; Nancy Fischbein; Seema Nagpal; Gordon Li; Norman Koglin; Mathias Berndt; Santiago Bullich; Andrew W Stephens; Ludger M Dinkelborg; Ty Abel; H Charles Manning; Jarrett Rosenberg; Frederick T Chin; Sanjiv Sam Gambhir; Erik S Mittra Journal: Radiology Date: 2022-02-22 Impact factor: 29.146
Authors: Ellen Merckx; Giulia Albertini; Magdalena Paterka; Cathy Jensen; Philipp Albrecht; Michael Dietrich; Joeri Van Liefferinge; Eduard Bentea; Lise Verbruggen; Thomas Demuyser; Lauren Deneyer; Jan Lewerenz; Geert van Loo; Jacques De Keyser; Hideyo Sato; Pamela Maher; Axel Methner; Ann Massie Journal: J Neuroinflammation Date: 2017-01-13 Impact factor: 8.322
Authors: Sara Belloli; Lucia Zanotti; Valentina Murtaj; Cristina Mazzon; Giuseppe Di Grigoli; Cristina Monterisi; Valeria Masiello; Leonardo Iaccarino; Andrea Cappelli; Pietro Luigi Poliani; Letterio Salvatore Politi; Rosa Maria Moresco Journal: J Neuroinflammation Date: 2018-02-05 Impact factor: 8.322
Authors: Aileen Hoehne; Michelle L James; Israt S Alam; John A Ronald; Bernadette Schneider; Aloma D'Souza; Timothy H Witney; Lauren E Andrews; Haley C Cropper; Deepak Behera; Gayatri Gowrishankar; Zhaoqing Ding; Tony Wyss-Coray; Frederick T Chin; Sandip Biswal; Sanjiv S Gambhir Journal: J Neuroinflammation Date: 2018-02-22 Impact factor: 8.322